NCT01433302|Completed
Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
Determination of the Effect of Lymphatico-venous Bypass Surgery on Inflammatory Responses and Tissue Fibrosis
Loading search results
Determination of the Effect of Lymphatico-venous Bypass Surgery on Inflammatory Responses and Tissue Fibrosis
Sponsor study identifier
Secondary identifiers
OTHER · Department of Defense
observational
21
1 country
1
Study Start
March 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2014
Actual (reported)Study Completion
March 2014
Actual (reported)The goal of this clinical research study is to measure the amount of inflammatory proteins inside the body before and after lymphatico-venular bypass surgery. This will help doctors learn if anti-fibrotic or anti-inflammatory drugs/treatments given with the surgery can improve how well the surgery works.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2014
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 8, 2011
Actual (reported)September 13, 2011
Actual (reported)March 2012
Date type not reportedThis date has not been verified as actual or estimated.
March 2014
Actual (reported)March 2014
Actual (reported)Th2 Cytokine Levels
5 mm punch biopsy specimens from the affected, lymphedematous limb will be obtained just prior to lymphatico-venular bypass and six (6) months after lymphatico-venular bypass. Punch biopsies will be obtained from the radial (lateral) aspect of the upper arm approximately 10cm above the olecranon process. Biopsy specimens will be collected from the contralateral (normal) arm at the exact same location.
6 months
5 mm punch biopsy specimens from the affected, lymphedematous limb will be obtained just prior to lymphatico-venular bypass and six (6) months after lymphatico-venular bypass. Punch biopsies will be obtained from the radial (lateral) aspect of the upper arm approximately 10cm above the olecranon process. Biopsy specimens will be collected from the contralateral (normal) arm at the exact same location.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
UT MD Anderson Cancer Center patients, 18 years of age or older, undergoing lymphatico-venular bypass for stage II or greater lymphedema.
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
David W. Chang, MD
M.D. Anderson Cancer Center
21 participants (actual enrollment reported by the registry).
First Submitted
September 8, 2011
First Posted
September 13, 2011
Study Start
March 2012
Date type not reportedThis date has not been verified as actual or estimated.
Differential Mobility Spectrometry (DMS) Based Skin Tumor Analysis
Contact the study team to confirm eligibility.
Primary Completion
March 2014
Actual (reported)Study Completion
March 2014
Actual (reported)Last Updated
May 6, 2015
Record last verified: 2015-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: